Telmisartan/Amlodipine/Lipitor 80/5/10 mg

Adult dose

This medication should be taken once daily, 1 tablet, with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For telmisartan/amlodipine combination therapy, individualized dosing based on patient response and tolerability is necessary. Examples of dosage adjustments for telmisartan/amlodipine combination therapy include: - 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg.

This medication should not be used during pregnancy. If pregnancy is confirmed, use should be discontinued immediately, and women who may become pregnant should use appropriate contraceptive methods. Patients with hypersensitivity to any components in this medication or those with certain genetic disorders should not take it. Moreover, patients with severe liver disease or renal failure and those with specific heart conditions should be cautious when taking this medication due to potential risks. Elderly patients or those with hypotension, hyperkalemia, or impaired liver function should exercise increased caution when taking this medication, and it is advisable to periodically monitor liver and kidney function. This medication may cause myalgia, myopathy, and in rare cases, severe muscle damage known as rhabdomyolysis, so patients should consult their physician immediately if symptoms such as myalgia or muscle weakness occur. Regular blood tests to check levels of creatine kinase (CK), a marker of muscle damage, are recommended, and if levels rise significantly, medication should be discontinued. Liver enzyme levels may also become abnormal, thus it is important to periodically test enzyme levels, and if they deviate significantly from the normal range, use should be stopped. This drug may interact with other antihypertensive or lipid-lowering medications, so it is imperative to inform the physician or pharmacist if other medications are being taken. It is advisable for breastfeeding women not to take this medication; if unavoidable, breastfeeding should be discontinued. In the case of overdose, symptoms such as hypotension, dizziness, and renal dysfunction may occur, and immediate medical attention should be sought in such instances. Patients should be cautious about dizziness or drowsiness occurring while driving or operating machinery during the use of this drug. It is not recommended for children as safety and efficacy have not been established in this population. Finally, this medication should be stored out of reach of children, and it is safer to avoid transferring it to other containers.

Serious side effects

Urticaria, angioedema, severe edema (swelling), unstable angina, angioedema, thrombocytopenia, acute renal failure, increased serum creatinine, liver dysfunction (including jaundice), hepatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), rhabdomyolysis, severe allergic reactions, severe skin reactions, dyspnea, asthma, acute renal failure

Mild side effects

• Headache
• dizziness
• dyspepsia
• frequent bowel movements
• diabetes
• dry cough
• urticaria
• unstable angina
• onychomycosis
• lumbar spinal stenosis

This medication is sensitive to light and should be stored in containers that block light. Additionally, the medication should be stored at room temperature, i.e., between 1 to 30 degrees Celsius. This way, the effects of the medication are well maintained and can be used safely.

Appearance

Oval bicolored tablet that consists of a white layer and a light blue layer

Package unit

30 tablets/box [10 tablets/PTP*3]